Sowell Financial Services LLC Novavax Inc Transaction History

Sowell Financial Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$121.0 - $257.67 $116,281 - $247,620	-961 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$112.98 - $319.93 $28,357 - $80,302	-251 Reduced 20.71%	961 $166,000
Q4 2020 Jan 13, 2021	BUY	$78.74 - $139.5 $78,503 - $139,081	997 Added 463.72%	1,212 $135,000
Q3 2020 Nov 12, 2020	SELL	$79.44 - $178.51 $158 - $357	-2 Reduced 0.92%	215 $23,000
Q2 2020 Aug 13, 2020	BUY	$13.86 - $83.61 $1,621 - $9,782	117 Added 117.0%	217 $18,000
Q1 2020 May 12, 2020	BUY	$3.93 - $16.0 $393 - $1,600	100 New	100 $1,000

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.